Alternate Text

Drug Safety Evaluation Service

General Toxicology Study, Irritation test, Allergy test, Hemolysis test, Reproductive and Developmental Toxicity Study, Genetic Toxicity Study, Immunogenicity Study, Safety Pharmacology Study, Toxicokinetics (TK) Study

More
Alternate Text

Pharmacodynamic Service

Tumor Pharmacodynamics Study, Cardiovascular Pharmacodynamics Study, Central Nervous Pharmacodynamics Study, Endocrine System Pharmacodynamics Study, Digestive System Pharmacodynamics Study.

More
Alternate Text

PharmacokineticsStudy Service

According to the requirements of the guiding principles, CTI BIOcarries out systematic pharmacokinetic studies, including in vivo and in vitro pharmacokinetics.

More
Alternate Text

Animal Disease Model

CTI BIO provides services includeMetabolic Disease Model, Cardiovascular & Central Nervous System Disease Model, Tumor Model and Other Models.

More

Alternate Text

News

MORE

中藥配方顆粒市場“百花齊放”背后,馬太效應加劇,隱憂仍未消除

2020/04/07

羥氯喹治療COVID-19最新臨床數據!顯著縮短發熱、咳嗽緩解時間,促進肺炎改善

2020/04/02

行業 | CPIA發文建議加快原料藥中間體生產供應 全球抗疫下中國原料藥產業地位凸顯

2020/03/30

造血干細胞表達Toll樣受體,多維度參與天然免疫

2020/03/26

Alternate Text

  • Alternate Text

    Plant area

  • Alternate Text

    Experimental Lab (phase 1)

  • Alternate Text

    SPF-grade animal rooms

  • Alternate Text

    conventional animal rooms

  • Alternate Text

    Auxiliary function Lab

  • Alternate Text

    Other area

The environmental temperature, humidity and pressure gradient ofanimal roomsin CTI BIOare monitored by Jonson Controls Central Air Conditioning Automation Control System, ensuring that the environmental indicators meet the requirements of GLP. CTI BIO adopts Pristima, an internationally recognized data acquisition and management system, to collect, analyze and manage experimental data to ensure its authenticity, reliability and safety.

Alternate Text

CTI BIO has an experienced/skilled team: 3 NMPA new drug reviewers and 2 GLP inspectors. The core technology team consists of more than 200 people, including 6 members with senior professional titles, and over 60% with bachelors degree or above, with education background in medicine, pharmacology, toxicology, animal medicine, biology, etc..

  • 4%

    DOCTORS

    Doctors degree
  • 16%

    MASTERS

    Masters degree
  • 41%

    BACHELOR

    Bachelor's degree

Alternate Text

CTI Biotechnology (SUZHOU) CO., LTD. (hereinafter referred as CTI BIO), is a CRO company specializing in the preclinical research for new drugs, invested by Center Testing International Group Co., Ltd. CTI BIO is committed to providing pre-clinical pharmacodynamics, toxicology, pharmacokinetics and biological analysis testing services for customers of domestic and oversea biomedical enterprises and scientific research institutions.

Natural Location

CTI Biotech is located in Kunshan High-tech Zone, adjacent to Suzhou Industrial Park and Shanghai, where is the core area of Yangtze River Delta.

More

Professional Facility

The facility of phase I building covers more than 13,300 square meters with laboratories in compliance with international GLP and national standards.

More

13,389m2

Experimental Lab (phase 1)

5,862m2

Conventional animal rooms

2,200m2

SPF-grade animal rooms

867m2

Auxiliary function Lab

Professional Technical Team

The core technology team consists of more than 200 people, with education background in medicine, pharmacology, toxicology, animal medicine, biology, etc.

More
Medical science
Pharmacology
Toxicology
Veterinary Medicine
Biology

Highly Educated

The core technology team consists of 6 members with senior professional titles, 4% with Doctors degree, over 60% with bachelors degree or above, 3 NMPA new drug reviewers and 2 GLP inspectors.

More

6

Senior titles

4%

Doctors degree

16%

Masters degree

3

NMPA new drug reviewers

2

GLP inspectors

Instruments and Equipment

Security surveillance and alarm system(Metasys, Jonson Controls, HVAC control system)

Pristima - data acquisition system following international standards

蘇州華測